February 10-11, Swiss Nordic Bio 2021

Oct 25, 2020

Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry.
  • The conference is the number one platform that gathers life science professionals from Switzerland and the Nordic countries under one roof.
  • The conference is organised by the Nordic countries in cooperation with Swiss partners.

Swiss Nordic Bio 2021 will be held on 10 February in digital format – the event will be live streamed and 1-to-1 meetings will be held virtually.

Homepage >>

About CombiGene

CombiGene’s vision is to provide patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. Development assets are sourced from an external research network and developed to achieve clinical proof of concept. Drug candidates for common diseases will be co-developed and commercialized through strategic partnerships, while the company may manage this process on its own for drugs targeting niched patient populations. The company is public and listed on the Swedish marketplace Nasdaq First North Growth Market and the company’s Certified Advisor is FNCA Sweden AB, +46 (0)852 80 03 99 info@fnca.se.

 

Combigene AB, Medicon Village, SE-223-81 Lund, Visiting adress: Scheelevägen 2, Lund, Sweden

Linked In     Twitter      Facebook